COMMUNIQUÉS West-GlobeNewswire

Shockwave Medical Reports First Quarter 2024 Financial Results
06/05/2024
SANTA CLARA, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular [...]
NEXGEL to Present at the Aegis Capital Virtual Conference on May 9, 2024
06/05/2024
LANGHORNE, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content [...]
Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update
06/05/2024
- Announced Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) - - Initiation of Phase 2 clinical trial for RT-102 for the treatment of osteoporosis expected in 2024 - - [...]
RxSight, Inc. Reports First Quarter 2024 Financial Results
06/05/2024
ALISO VIEJO, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, [...]
LAVA Therapeutics to Participate in the Citizens JMP Life Sciences Conference
06/05/2024
UTRECHT, The Netherlands and PHILADELPHIA, May 06, 2024 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (NASDAQ: LVTX, “LAVA,” or “Company”), a clinical-stage immuno-oncology company focused on developing its proprietary [...]
Exagen Announces Campaign for Lupus Awareness Month
06/05/2024
CARLSBAD, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of a campaign [...]
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
06/05/2024
BEACON-IPF pivotal, adaptive Phase 2b/3 trial design implementation significantly accelerates bexotegrast development in IPF Data from completed 12 week Phase 2a imaging trial measuring bexotegrast’s effect on total [...]
OrthoPediatrics Corp. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance
06/05/2024
First Quarter 2024 Revenue Increased 41% Year-over-Year WARSAW, Ind., May 06, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on [...]
FibroGen Reports First Quarter 2024 Financial Results
06/05/2024
Topline data from the Pancreatic Cancer Action Network (PanCAN) Precision Promise SM Phase 2/3 study in metastatic pancreatic cancer anticipated in mid-2024 Topline data from LAPIS Phase 3 study in locally advanced [...]
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
06/05/2024
Soquelitinib Phase 1 Randomized Trial in Atopic Dermatitis Enrolling at Multiple Centers; Potential for Early Data Before Year-End 2024 Soquelitinib Registration Phase 3 Trial in Peripheral T Cell Lymphoma Advancing [...]
Travere Therapeutics Reports First Quarter 2024 Financial Results
06/05/2024
FDA grants Priority Review for sNDA to convert FILSPARI ® (sparsentan) from accelerated approval to full approval for the treatment of IgAN in the U.S.; PDUFA target action date of September 5, 2024 Received 511 new [...]
Assertio Reports First Quarter 2024 Financial Results
06/05/2024
First Quarter Net Product Sales of $31.9 Million Rolvedon Growth Continues, with $14.5 million in Net Product Sales $7.5 Million in Cash Flow from Operations Increases Cash to $80.7 Million LAKE FOREST, Ill., May 06, [...]
Celldex Reports First Quarter 2024 Financial Results and Provides Corporate Update
06/05/2024
- Phase 3 CSU studies expected to initiate in summer 2024 - - Positive Phase 2 CSU 12 week data reported in late breaking oral presentation at AAAAI 2024; 52 week data to be reported in 2H 2024 - - Enrollment completed [...]
The Association of American Physicians and Surgeons (AAPS) Files Brief in the Ohio Supreme Court to Defend Children against Transgender Operations
06/05/2024
TUCSON, Ariz., May 06, 2024 (GLOBE NEWSWIRE) -- The Association of American Physicians and Surgeons (AAPS) has filed an amicus brief in the Supreme Court of Ohio to defend children against transgender operations. The [...]
HEALWELL AI Inc. Announces Upsize of Bought Deal to Up to $20 Million
06/05/2024
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI INC. (“ HEALWELL ” or the “ Company ”) (TSX: AIDX) is pleased to [...]
Trading in Novo Nordisk shares by board members, executives and associated persons
06/05/2024
Bagsværd, Denmark, 06 May 2024 – This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with [...]
Novo Nordisk A/S - share repurchase programme
06/05/2024
Bagsværd, Denmark, 06 May 2024 – The execution of Novo Nordisk A/S’ overall share repurchase programme for 2024 of DKK 20 billion continues. As part of this, Novo Nordisk A/S has now initiated a new share repurchase [...]
Novo Nordisk A/S purchases B shares worth DKK 5,428 million from Novo Holdings A/S under the 2024 share repurchase programme
06/05/2024
Bagsværd, Denmark, 06 May 2024 – Today, Novo Nordisk A/S has entered into an agreement to purchase 6,311,250 B shares of DKK 0.10 at a value of DKK 5,427,801,225.00 million from Novo Holdings A/S. The transaction is [...]
NMDP’s Amy Ronneberg Recognized as Most Admired CEO by Minneapolis/St. Paul Business Journal
06/05/2024
MINNEAPOLIS, May 06, 2024 (GLOBE NEWSWIRE) -- NMDP SM , a global nonprofit leader in cell therapy, announced today that the Minneapolis / St. Paul Business Journal named CEO Amy Ronneberg to its 2024 list of Most [...]

Pages